19 PARTICIPATING COUNTRIESa
The Advanced Diagnostic Profiling (ADPro) sub-study aims to precisely characterise patients with physician-assigned asthma and/or COPD from NOVELTY using imaging and physiological and metabolic measures. In 3 minutes, this video explains the hyperpolarised 129Xe gas magnetic resonance imaging (MRI) technique that is being used in the ADPro sub-study to image patient lungs.
You are now leaving: http://aznoveltyproject.com/
By following this link you will be leaving the NOVELTY study website.
Please note that AstraZeneca does not take responsibility for the content displayed on other websites.